Turning foes to friends: targeting cancer-associated fibroblasts
暂无分享,去创建一个
[1] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[2] S. Andò,et al. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: Connecting TGF-β signaling with “Warburg-like” cancer metabolism and L-lactate production , 2012, Cell cycle.
[3] Chunsheng Zhang,et al. Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. , 2017, Cancer cell.
[4] I. Haviv,et al. Origin of carcinoma associated fibroblasts , 2009, Cell cycle.
[5] G. Wahl,et al. Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy , 2014, Cell.
[6] James O. Jones,et al. Suppression of Antitumor Immunity by Stromal Cells Expressing , 2022 .
[7] Xiao-Jun Ma,et al. Gene expression profiling of the tumor microenvironment during breast cancer progression , 2009, Breast Cancer Research.
[8] J. Foekens,et al. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression , 2003, Thrombosis and Haemostasis.
[9] R. Tomasini,et al. Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance , 2015, EMBO molecular medicine.
[10] Jiwang Zhang,et al. Osteopontin Mediates an MZF1-TGF-β1-Dependent Transformation of Mesenchymal Stem Cells into Cancer Associated Fibroblasts in Breast Cancer , 2014, Oncogene.
[11] C. Betsholtz,et al. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.
[12] J. Nemunaitis,et al. AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer , 2015, Science Translational Medicine.
[13] J. Scheuermann,et al. Diagnostic and therapeutic applications of recombinant antibodies: targeting the extra-domain B of fibronectin, a marker of tumor angiogenesis. , 2004, Current pharmaceutical design.
[14] Richard A. Flavell,et al. The polarization of immune cells in the tumour environment by TGFβ , 2010, Nature Reviews Immunology.
[15] B. Eyden. The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine , 2007, Journal of cellular and molecular medicine.
[16] P. Jung,et al. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. , 2012, Cancer cell.
[17] D. Jäger,et al. Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer , 2003, Oncology Research and Treatment.
[18] C. Datz,et al. Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver , 2010, Proceedings of the National Academy of Sciences.
[19] Robert A. Weinberg,et al. Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts , 2010, Proceedings of the National Academy of Sciences.
[20] Å. Borg,et al. Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties. , 2014, Cancer research.
[21] H. Dvorak. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.
[22] Umar Mahmood,et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. , 2014, Cancer cell.
[23] T. Sjöblom,et al. STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer. , 2013, Cancer research.
[24] K. Wiman,et al. Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death , 2017, Cell Death & Disease.
[25] A. Vincent-Salomon,et al. Oxidative stress promotes myofibroblast differentiation and tumour spreading , 2010, EMBO molecular medicine.
[26] Pixu Liu,et al. An Anti-inflammatory Function for the Complement Anaphylatoxin C5a-binding Protein, C5L2* , 2005, Journal of Biological Chemistry.
[27] P. Stattin,et al. Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients , 2009, The Prostate.
[28] Derek S. Chan,et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer , 2013, Proceedings of the National Academy of Sciences.
[29] Jean Paul Thiery,et al. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[31] J. Nemunaitis,et al. Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] J. Foekens,et al. Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma , 2013, Cell.
[33] Z. Werb,et al. Remodelling the extracellular matrix in development and disease , 2014, Nature Reviews Molecular Cell Biology.
[34] Peter Olson,et al. Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.
[35] E. Puré,et al. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. , 2009, The Journal of clinical investigation.
[36] D. Kranz. Faculty Opinions recommendation of Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. , 2010 .
[37] T. Wynn,et al. Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.
[38] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[39] M. Ewen,et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. , 2011, Cancer cell.
[40] Robert P. Jenkins,et al. Mechano-transduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer associated fibroblasts , 2013, Nature Cell Biology.
[41] Hao Liu,et al. Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[42] C. Pilarsky,et al. CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer , 2013, Proceedings of the National Academy of Sciences.
[43] T. Lebien,et al. The common acute lymphoblastic leukemia antigen (CD10)--emancipation from a functional enigma. , 1989, Blood.
[44] P. Carmeliet,et al. Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.
[45] E. Cukierman,et al. Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors. , 2010, Seminars in cancer biology.
[46] T. Kim,et al. The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment. , 2012, Biochemical and biophysical research communications.
[47] D. Fearon,et al. Tumoral Immune Suppression by Macrophages Expressing Fibroblast Activation Protein-α and Heme Oxygenase-1 , 2013, Cancer Immunology Research.
[48] Robert J Snyder,et al. Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial , 2012, The Lancet.
[49] Metin N. Gurcan,et al. Pten in Stromal Fibroblasts Suppresses Mammary Epithelial Tumors , 2009, Nature.
[50] Jennifer R. Grandis,et al. Targeting the IL-6/JAK/STAT3 signalling axis in cancer , 2018, Nature Reviews Clinical Oncology.
[51] M. A. Huber,et al. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. , 2003, The Journal of investigative dermatology.
[52] Erik Sahai,et al. ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. , 2011, Cancer cell.
[53] Carlos Cuevas,et al. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.
[54] Liang Xie,et al. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. , 2007, Cancer research.
[55] M. Poupon,et al. Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases. , 1986, Cancer research.
[56] P. Conti,et al. A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice , 2016, International journal of cancer.
[57] Ross Tubo,et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.
[58] David Allard,et al. Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.
[59] X. Yuan,et al. The IL-6–STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression , 2014, Cell Death and Disease.
[60] P. Platzer,et al. Breast-cancer stromal cells with TP53 mutations and nodal metastases. , 2007, The New England journal of medicine.
[61] M J Bissell,et al. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.
[62] V. LeBleu,et al. EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer , 2015, Nature.
[63] H. Rodemann,et al. Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[64] Joel s. Brown,et al. Classifying the evolutionary and ecological features of neoplasms , 2017, Nature Reviews Cancer.
[65] R. Bourgon,et al. TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells , 2018, Nature.
[66] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[67] S. Eschrich,et al. Tumour radiosensitivity is associated with immune activation in solid tumours. , 2017, European journal of cancer.
[68] D. Loew,et al. Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane , 2017, Nature Communications.
[69] L. Lund,et al. Plasminogen activation and cancer , 2005, Thrombosis and Haemostasis.
[70] Raghu Kalluri,et al. Exosomes in tumor microenvironment influence cancer progression and metastasis , 2013, Journal of Molecular Medicine.
[71] Olivier De Wever,et al. Stromal myofibroblasts are drivers of invasive cancer growth , 2008, International journal of cancer.
[72] D. Stainier,et al. Hepatic stellate cells in liver development, regeneration, and cancer. , 2013, The Journal of clinical investigation.
[73] B. Krishnamachary,et al. Structure and Function of a Prostate Cancer Dissemination–Permissive Extracellular Matrix , 2016, Clinical Cancer Research.
[74] A. Jemal,et al. Global Cancer Statistics , 2011 .
[75] D. Weiner,et al. Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice , 2018, Clinical Cancer Research.
[76] D. Gurwitz. Emerging therapeutic targets , 1998 .
[77] J. Mesirov,et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. , 2008, Cancer research.
[78] Hans Clevers,et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer , 2017, The Journal of experimental medicine.
[79] Marc L. Mendillo,et al. The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy , 2014, Cell.
[80] Hans Clevers,et al. Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression. , 2011, Gastroenterology.
[81] Yu-mei Feng,et al. Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling , 2013, British Journal of Cancer.
[82] T. Sjöblom,et al. Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15. , 2014, Cancer research.
[83] E. Giannoni,et al. Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression , 2014, Oncogene.
[84] N. Lemoine,et al. Anti‐stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma , 2016, The Journal of pathology.
[85] Kenneth J. Pienta,et al. Recruitment of Mesenchymal Stem Cells Into Prostate Tumors Promotes Metastasis , 2013, Nature Communications.
[86] Andrii Savchenko,et al. Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent , 2014, Proceedings of the National Academy of Sciences.
[87] Hongyang Wang,et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer , 2018, Nature Communications.
[88] E. Puré,et al. Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity , 2013, Cancer Immunology Research.
[89] M. Omary,et al. The pancreatic stellate cell: a star on the rise in pancreatic diseases. , 2007, The Journal of clinical investigation.
[90] N. Fusenig,et al. Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.
[91] J. Gribben,et al. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. , 2013, Gastroenterology.
[92] D. Sullivan,et al. A Phase I Pharmacokinetic and Pharmacodynamic Study of S-3304, a Novel Matrix Metalloproteinase Inhibitor, in Patients with Advanced and Refractory Solid Tumors , 2007, Clinical Cancer Research.
[93] Mingzhu Huang,et al. Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction , 2010, Journal of experimental & clinical cancer research : CR.
[94] T. Petrova,et al. Microenvironmental regulation of tumour angiogenesis , 2017, Nature Reviews Cancer.
[95] A. Aboussekhra,et al. p16INK4A Represses the paracrine tumor-promoting effects of breast stromal fibroblasts , 2012, Oncogene.
[96] Ricardo Garcia,et al. Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis , 2011, Cell.
[97] James O. Jones,et al. Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia , 2013, The Journal of experimental medicine.
[98] D. Sidransky,et al. Abstract 1287: Epigenetic deregulation of breast cancer is associated with DNA Repair Capacity. , 2013 .
[99] D. Zwijnenburg,et al. Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion , 2016, Oncogene.
[100] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[101] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[102] E. Neilson,et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.
[103] Christine A Iacobuzio-Donahue,et al. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular-fibrosis and tumor progression , 2016, Nature Medicine.
[104] Olivier Molinier,et al. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial , 2016, The Lancet.
[105] Douglas B. Evans,et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. , 2008, Cancer research.
[106] D. Hanahan,et al. Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting , 2008, PLoS medicine.
[107] Mikala Egeblad,et al. Dynamic interplay between the collagen scaffold and tumor evolution. , 2010, Current opinion in cell biology.
[108] J. Lieberman,et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer , 2017, Cell Research.
[109] J. Mpindi,et al. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer , 2011, Oncogene.
[110] Ying Sun,et al. RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer. , 2012, Cancer research.
[111] M. Lisanti,et al. Role of caveolae and caveolins in health and disease. , 2004, Physiological reviews.
[112] C. Rueden,et al. Bmc Medicine Collagen Density Promotes Mammary Tumor Initiation and Progression , 2022 .
[113] R. Moll,et al. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions , 2002, Virchows Archiv.
[114] G. Eberl,et al. Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury , 2012, Nature Medicine.
[115] F. Lovat,et al. Targeted Intraoperative Radiotherapy Impairs the Stimulation of Breast Cancer Cell Proliferation and Invasion Caused by Surgical Wounding , 2008, Clinical Cancer Research.
[116] R. Kalluri. The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.
[117] D. Pisano,et al. Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer , 2016, Gut.
[118] C. Martins,et al. Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells , 2018, Nature Communications.
[119] Yufang Shi,et al. Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets , 2016, Nature Reviews Drug Discovery.
[120] P. Hein,et al. Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.
[121] R. Vandenbroucke,et al. Is there new hope for therapeutic matrix metalloproteinase inhibition? , 2014, Nature Reviews Drug Discovery.
[122] Dong Eun Kim,et al. Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation , 2015, Nature Cell Biology.
[123] R. Hill,et al. CANCER-ASSOCIATED FIBROBLAST EXOSOMES REGULATE SURVIVAL AND PROLIFERATION OF PANCREATIC CANCER CELLS , 2016, Oncogene.
[124] Noriyuki Nishimura,et al. Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development , 2016, The Journal of pathology.
[125] William Y. Kim,et al. Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors. , 2017, Cancer research.
[126] Jinhua Zhang,et al. Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens. , 2013, Cancer research.
[127] J. Healey,et al. Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles. , 2017, Cancer research.
[128] Raghu Kalluri,et al. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization , 2011, Proceedings of the National Academy of Sciences.
[129] Yuquan Wei,et al. Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer. , 2017, Cancer research.
[130] M. Monden,et al. Stromal Myofibroblasts Predict Disease Recurrence for Colorectal Cancer , 2007, Clinical Cancer Research.
[131] C. Jean,et al. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts , 2016, Oncotarget.
[132] E. Giannoni,et al. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. , 2010, Cancer research.
[133] M. Grigorian,et al. Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene. , 2005, Cancer research.
[134] Q. Gao,et al. Telomere length variation in tumor cells and cancer‐associated fibroblasts: potential biomarker for hepatocellular carcinoma , 2017, The Journal of pathology.
[136] G. McCaughan,et al. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX‐2 human stellate cell line , 2005, Hepatology.
[137] Aled Clayton,et al. Cancer exosomes trigger fibroblast to myofibroblast differentiation. , 2010, Cancer research.
[138] B. Hinz,et al. Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.
[139] R. Holcombe,et al. Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer , 2016, Clinical Cancer Research.
[140] Takuya Kato,et al. A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion , 2017, Nature Cell Biology.
[141] Rameen Beroukhim,et al. Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.
[142] S. Larson,et al. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[143] L. Ferrucci,et al. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance , 2016, Nature.
[144] Austin E. Gillen,et al. Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen , 2016, Clinical Cancer Research.
[145] H. Yao,et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. , 2014, Cancer cell.
[146] Hsiao-Chin Hong,et al. Targeting Galectin-1 in Carcinoma-Associated Fibroblasts Inhibits Oral Squamous Cell Carcinoma Metastasis by Downregulating MCP-1/CCL2 Expression , 2011, Clinical Cancer Research.
[147] P. Tonin,et al. Breast carcinoma-associated fibroblasts rarely contain p53 mutations or chromosomal aberrations. , 2010, Cancer research.
[148] P. Beachy,et al. Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[149] M. Okumura,et al. IL‐6 Secreted from Cancer‐Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial‐Mesenchymal Transition Signaling , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[150] Janna Paulsson,et al. Prognostic relevance of cancer-associated fibroblasts in human cancer. , 2014, Seminars in cancer biology.
[151] Rakesh K. Jain,et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels , 2013, Nature Communications.
[152] T. Golub,et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion , 2012, Nature.
[153] V. Heinemann,et al. Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial , 2015, BMC Cancer.
[154] Hiroyuki Tomita,et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. , 2011, Cancer cell.
[155] V. Sanz-Moreno,et al. Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts , 2015, Nature Communications.
[156] David R Bickers,et al. Sonic hedgehog signaling in Basal cell nevus syndrome. , 2014, Cancer research.
[157] T. Gress,et al. Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer , 2017, Gut.
[158] R. Virchow,et al. Die Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebelehre , 1861 .
[159] M. Loeffler,et al. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. , 2006, The Journal of clinical investigation.
[160] C. O'neill,et al. Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts. , 1966, Journal of cell science.
[161] B. Hennessy,et al. Adipose Tissue-Derived Stem Cells Differentiate into Carcinoma-Associated Fibroblast-Like Cells under the Influence of Tumor-Derived Factors , 2010, Analytical cellular pathology.
[162] S. Leeder,et al. A population based study , 1993, The Medical journal of Australia.
[163] M. Shekhar,et al. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. , 2001, Cancer research.
[164] E. Sahai,et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells , 2007, Nature Cell Biology.
[165] Christopher K. Glass,et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis , 2012, Proceedings of the National Academy of Sciences.
[166] M. Olson,et al. Regulation of pancreatic cancer aggressiveness by stromal stiffening , 2016, Nature Medicine.
[167] Yuli Lin,et al. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling. , 2016, Cancer research.
[168] Daniel Öhlund,et al. Fibroblast heterogeneity in the cancer wound , 2014, The Journal of experimental medicine.
[169] E. Puré,et al. Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells. , 2015, Cancer research.
[170] G. Bratthauer,et al. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. , 2000, Cancer research.
[171] Robert A. Weinberg,et al. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.
[172] A. Scott,et al. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[173] H. Yao,et al. CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness , 2018, Cell.
[174] J. Lieberman,et al. let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells , 2007, Cell.
[175] D. Hanahan,et al. A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance , 2018, Cell.
[176] S. Linn,et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. , 2016, The Lancet. Oncology.
[177] Justin C. Grindley,et al. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery , 2009, Nature Reviews Drug Discovery.
[178] I. Ng,et al. Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling. , 2016, Cell reports.
[179] J. Takagi,et al. Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression. , 2018, Cell stem cell.
[180] B. Hennessy,et al. Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors , 2011, Cellular Oncology.
[181] V. Speirs,et al. Clinical and functional significance of loss of caveolin‐1 expression in breast cancer‐associated fibroblasts , 2012, The Journal of pathology.
[182] G. Collins. The next generation. , 2006, Scientific American.
[183] R. Weinberg,et al. Reconstruction of functionally normal and malignant human breast tissues in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[184] Gerhard Christofori,et al. The angiogenic switch in carcinogenesis. , 2009, Seminars in cancer biology.
[185] Stephen A. Sastra,et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. , 2014, Cancer cell.
[186] R. Coleman,et al. Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[187] Umar Mahmood,et al. Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival. , 2015, Cancer cell.
[188] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[189] D. Quail,et al. Microenvironmental regulation of tumor progression and metastasis , 2014 .
[190] Derek S. Chan,et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer , 2012, Gut.
[191] Richard A Flavell,et al. Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation. , 2011, Immunity.
[192] P. Scardino,et al. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[193] K. Heider,et al. Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine Protease of Tumor Fibroblasts , 2008, Clinical Cancer Research.
[194] Chunsheng Zhang,et al. Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers , 2010, Proceedings of the National Academy of Sciences.
[195] I. Flinn,et al. Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial. , 2016, The Lancet. Oncology.
[196] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .